Author:
Das Abhijit,Mondal Hindol
Publisher
Jaypee Brothers Medical Publishing
Reference23 articles.
1. 1. Merskey H, Bogduk N. Task force on taxonomy of the International Association for the Study of Pain. Classification of Chronic Pain Descriptions of Chronic Pain Syndromes and Definitions of Pain Terms, 2nd ed., Seattle: IASP Press; 2002. p. 212.
2. 2. Beniczky S, Tajti J, Timea VE, et al. Evidence-based pharmacological treatment of neuropathic pain syndromes. J Neural Transm (Vienna) 2005;112(6):735–749. DOI: 10.1007/s00702-005-0300-x.
3. 3. Van Hecke O, Austin SK, Khan RA, et al. Neuropathic pain in the general population: a systematic review of epidemiological studies. Pain 2014;155(4):654–662. DOI: 10.1016/j.pain.2013. 11.013.
4. 4. Bansal D, Gudala K, Muthyala H, et al. Prevalence and risk factors of development of peripheral diabetic neuropathy in type 2 diabetes mellitus in a tertiary care setting. J Diabetes Investig 2014;5(6): 714–721. DOI: 10.1111/jdi.12223.
5. 5. Finnerup NB, Attal N, Haroutounian S, et al. Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. Lancet Neurol 2015;14(2):162–173. DOI: 10.1016/S1474-4422(14)70251-0.